1-Benzyl-3-propyl-1H-1,3,4b,9-tetraaza-fluorene-2,4-dione

ID: ALA322250

Chembl Id: CHEMBL322250

PubChem CID: 10359522

Max Phase: Preclinical

Molecular Formula: C19H18N4O2

Molecular Weight: 334.38

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCn1c(=O)c2c(nc3ccccn32)n(Cc2ccccc2)c1=O

Standard InChI:  InChI=1S/C19H18N4O2/c1-2-11-22-18(24)16-17(20-15-10-6-7-12-21(15)16)23(19(22)25)13-14-8-4-3-5-9-14/h3-10,12H,2,11,13H2,1H3

Standard InChI Key:  LDLBAAURBBVHGB-UHFFFAOYSA-N

Alternative Forms

Associated Targets(Human)

ADORA1 Tclin Adenosine A1 receptor (17603 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA2A Tclin Adenosine A2a receptor (16305 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA3 Tchem Adenosine A3 receptor (15931 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
ADORA1 Tclin Adenosine receptors; A1 & A3 (1051 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 334.38Molecular Weight (Monoisotopic): 334.1430AlogP: 2.27#Rotatable Bonds: 4
Polar Surface Area: 61.30Molecular Species: NEUTRALHBA: 6HBD:
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: 2.74CX LogD: 2.74
Aromatic Rings: 4Heavy Atoms: 25QED Weighted: 0.58Np Likeness Score: -1.81

References

1. Priego EM, von Frijtag Drabbe Kuenzel J, IJzerman AP, Camarasa MJ, Pérez-Pérez MJ..  (2002)  Pyrido[2,1-f]purine-2,4-dione derivatives as a novel class of highly potent human A(3) adenosine receptor antagonists.,  45  (16): [PMID:12139445] [10.1021/jm0208469]
2. Baraldi PG, Preti D, Borea PA, Varani K..  (2012)  Medicinal chemistry of A₃ adenosine receptor modulators: pharmacological activities and therapeutic implications.,  55  (12): [PMID:22468757] [10.1021/jm300087j]
3. Faudone G, Arifi S, Merk D..  (2021)  The Medicinal Chemistry of Caffeine.,  64  (11.0): [PMID:34019396] [10.1021/acs.jmedchem.1c00261]

Source